Noteworthily, stable transfection with an ion translocation-defective NHE1 reduces both gene expression and activity of MMP9 [119], and in breast cancer cells, NHE1 inhibition blocks the CD44-dependent increase in cathepsin B maturation and activity [10]. The gene discussed is SLC9A1; the disease is breast cancer.